Which has the lower trailing P/E, DXCM or IQV?

IQV has the lower trailing P/E: DXCM trades at 32.98 and IQV at 29.16. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, DXCM or IQV?

Over the past five years, DXCM grew revenue faster — DXCM at a 18.03% CAGR versus IQV at 5.61%.

Is DXCM or IQV more profitable?

DXCM runs the higher net margin — DXCM at 20.12% versus IQV at 8.10%.

How have DXCM and IQV total returns compared?

Over the past 10 years, DXCM delivered 13.72% and IQV delivered 11.71% annualized total return. Past performance doesn't predict future results.

DexCom, Inc. (DXCM) vs IQVIA Holdings Inc. (IQV)

A side-by-side comparison of DexCom, Inc. and IQVIA Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 31, 2026. Differences are shown without an overall score or investment verdict.

DXCM

DexCom, Inc.

$32.20B

$83.45HealthcareDelayed quote: Jul 31, 2026, 4:00 PM EDT

IQV

IQVIA Holdings Inc.

$38.68B

$235.02HealthcareDelayed quote: Jul 31, 2026, 4:00 PM EDT

Total return — DXCM vs IQV

growth of $100 · dividends reinvested · last 13y

DXCM +1742.2%IQV +458.1%DXCM compounded faster

DXCM IQV

DXCM vs IQV: by the numbers

•IQV is the larger company ($38.68B vs $32.20B market cap).
•IQV trades at the lower trailing earnings multiple (29.16 vs 32.98 P/E), one valuation lens rather than an overall verdict.
•DXCM converts more revenue to profit (20.12% vs 8.10% net margin).
•DXCM grew revenue faster over the past five years (18.03% vs 5.61% CAGR).

Metrics side by side

Valuation

Metric	DXCM	IQV
P/E ratio	32.98	29.16
Forward P/E	31.86	18.14
P/S ratio	6.58	2.33
P/B ratio	12.47	6.42
PEG ratio	0.67	6.34
EV / EBITDA	25.98	15.47
FCF yield	4.30%	7.41%

Profitability

Metric	DXCM	IQV
Gross margin	62.79%	26.23%
Operating margin	22.92%	13.57%
Net margin	20.12%	8.10%
ROE	38.14%	22.28%
ROIC	16.61%	8.23%

Growth (annualized)

Metric	DXCM	IQV
Revenue CAGR (5Y)	18.03%	5.61%
EPS CAGR (5Y)	10.31%	40.21%
FCF CAGR (5Y)	69.49%	6.92%
Total return CAGR (5Y)	-8.32%	-1.05%

Frequently asked

Which has the lower trailing P/E, DXCM or IQV?: IQV has the lower trailing P/E: DXCM trades at 32.98 and IQV at 29.16. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, DXCM or IQV?: Over the past five years, DXCM grew revenue faster — DXCM at a 18.03% CAGR versus IQV at 5.61%.
Is DXCM or IQV more profitable?: DXCM runs the higher net margin — DXCM at 20.12% versus IQV at 8.10%.
How have DXCM and IQV total returns compared?: Over the past 10 years, DXCM delivered 13.72% and IQV delivered 11.71% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DXCM analysis Full IQV analysis Interactive comparison tool

Dig into the metrics

DexCom P/E ratio IQVIA P/E ratio DexCom dividend yield IQVIA dividend yield DexCom ROE IQVIA ROE DexCom operating margin IQVIA operating margin DexCom revenue growth IQVIA revenue growth DexCom free cash flow IQVIA free cash flow

DexCom & IQVIA appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 31, 2026.